Commonwealth Equity Services LLC bought a new stake in Select Medical Holdings Co. (NYSE:SEM) during the 1st quarter, HoldingsChannel.com reports. The firm bought 9,322 shares of the health services provider’s stock, valued at approximately $317,000.
Several other large investors also recently bought and sold shares of SEM. Norges Bank acquired a new stake in shares of Select Medical in the fourth quarter valued at approximately $34,796,000. SummerHaven Investment Management LLC acquired a new stake in shares of Select Medical in the fourth quarter valued at approximately $812,000. Fuller & Thaler Asset Management Inc. increased its holdings in shares of Select Medical by 58.7% in the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 2,096,540 shares of the health services provider’s stock valued at $57,990,000 after purchasing an additional 775,484 shares during the last quarter. BlackRock Inc. increased its holdings in shares of Select Medical by 2.8% in the fourth quarter. BlackRock Inc. now owns 17,204,770 shares of the health services provider’s stock valued at $475,885,000 after purchasing an additional 473,684 shares during the last quarter. Finally, Morgan Stanley increased its stake in Select Medical by 108.1% during the fourth quarter. Morgan Stanley now owns 590,692 shares of the health services provider’s stock worth $16,338,000 after acquiring an additional 306,785 shares during the last quarter. 76.03% of the stock is owned by hedge funds and other institutional investors.
Several equities research analysts have issued reports on SEM shares. Zacks Investment Research cut Select Medical from a “strong-buy” rating to a “hold” rating and set a $40.00 target price for the company. in a research note on Monday, May 3rd. Bank of America raised Select Medical from an “underperform” rating to a “buy” rating and raised their target price for the stock from $30.00 to $36.00 in a research note on Friday, February 26th. Benchmark raised their target price on Select Medical from $40.00 to $44.00 and gave the stock a “buy” rating in a research note on Thursday, May 13th. Deutsche Bank Aktiengesellschaft raised their target price on Select Medical from $42.00 to $46.00 and gave the stock a “buy” rating in a research note on Monday, May 17th. Finally, Credit Suisse Group lifted their price objective on Select Medical from $32.00 to $34.00 and gave the company a “neutral” rating in a research note on Monday, March 1st. Two research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. The company has a consensus rating of “Buy” and a consensus price target of $40.00.
Select Medical (NYSE:SEM) last released its earnings results on Thursday, May 6th. The health services provider reported $0.82 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.65 by $0.17. The firm had revenue of $1.55 billion during the quarter, compared to analyst estimates of $1.43 billion. Select Medical had a return on equity of 25.24% and a net margin of 5.59%. Select Medical’s revenue was up 9.3% compared to the same quarter last year. During the same period last year, the business posted $0.37 earnings per share. As a group, analysts expect that Select Medical Holdings Co. will post 2.56 EPS for the current year.
The business also recently announced a quarterly dividend, which was paid on Tuesday, June 1st. Investors of record on Wednesday, May 19th were issued a $0.125 dividend. The ex-dividend date was Tuesday, May 18th. This is a positive change from Select Medical’s previous quarterly dividend of $0.10. This represents a $0.50 dividend on an annualized basis and a yield of 1.22%. Select Medical’s dividend payout ratio (DPR) is 26.46%.
In related news, EVP Martin F. Jackson sold 100,000 shares of Select Medical stock in a transaction on Wednesday, May 26th. The stock was sold at an average price of $40.15, for a total value of $4,015,000.00. Following the completion of the transaction, the executive vice president now directly owns 1,285,428 shares in the company, valued at $51,609,934.20. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, EVP Martin F. Jackson sold 50,000 shares of Select Medical stock in a transaction on Friday, May 28th. The shares were sold at an average price of $40.07, for a total value of $2,003,500.00. Following the completion of the transaction, the executive vice president now owns 1,135,428 shares of the company’s stock, valued at $45,496,599.96. The disclosure for this sale can be found here. Over the last quarter, insiders sold 185,040 shares of company stock valued at $7,306,833. 18.80% of the stock is currently owned by company insiders.
Select Medical Company Profile
Select Medical Holdings Corporation, through its subsidiary, Select Medical Corporation, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. The company's Critical Illness Recovery Hospital segment consists of hospitals that provide services for heart failure, infectious disease, respiratory failure and pulmonary disease, surgery requiring prolonged recovery, renal disease, neurological events, and trauma.
Want to see what other hedge funds are holding SEM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Select Medical Holdings Co. (NYSE:SEM).
Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.